Real Brokerage Inc (REAX)
Official siteREAL ESTATE • REAL ESTATE SERVICES • NASDAQ
Market Cap: $405.91M
Last updated: Nov 17, 2026 at 11:06 AM ET
Real Brokerage Inc (REAX) Stock Forecast
Analysts expect Real Brokerage (REAX) to earn -$3.56 per share in the fiscal year ending Dec 31, 2026, on revenue of $2.53B. Of 7 analysts, 7 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 7 ratings average 1.86, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 14.3% |
| Buy | 6 | 85.7% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 7
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus turns from a loss to a profit and revenue estimates rise 10.3%.
- Fiscal year ending Dec 31, 2026
- -$3.56
- EPS consensus, revenue $2.53B
- Fiscal year ending Dec 31, 2027
- $0.20
- EPS consensus, revenue $2.79B
- Next report
- Mar 2, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$3.56 | -$4.26 to -$2.78 | 3 | $2.53B | $2.49B to $2.62B | 5 |
| Dec 31, 2027 | $0.20 | -$0.69 to $1.12 | 4 | $2.79B | $2.69B to $3.13B | 5 |
Quarterly Estimates
The EPS consensus falls from -$0.15 for the quarter ending Dec 31, 2026 to -$0.43 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.15 | -$0.29 to $0.00 | 7 | $582.60M | $469.33M to $692.37M | 9 |
| Mar 31, 2027 | -$0.43 | -$0.45 to -$0.40 | 2 | $563.09M | $512.10M to $614.00M | 4 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 1 upward and 1 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.05.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$3.56 | -$0.14 | -$0.39 | -$0.34 | -$0.05 | N/A |
| Fiscal year ending Dec 31, 2027 | $0.20 | $1.85 | $1.26 | $1.28 | $0.04 | +393.8% |
| Quarter ending Mar 31, 2027 | -$0.43 | N/A | N/A | N/A | -$0.01 | N/A |
Frequently Asked Questions About REAX
What is the REAX stock forecast?
Consensus analyst estimates put Real Brokerage's EPS at -$3.56 for the fiscal year ending Dec 31, 2026, on revenue of $2.53B. The consensus rating from 7 analysts is Buy.
How do analysts rate REAX stock?
Of 7 analysts covering Real Brokerage, 1 rates it Strong Buy, 6 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from REAX next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$3.56, with estimates from -$4.26 to -$2.78 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.20, with estimates from -$0.69 to $1.12 from 4 analysts.
What revenue do analysts expect from Real Brokerage next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $2.53B, with estimates from $2.49B to $2.62B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $2.79B, with estimates from $2.69B to $3.13B.
How many analysts cover REAX?
7 analysts rate Real Brokerage stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
REAX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors